Induced apoptosis in human prostate cancer cell line LNCaP by Ukrain

Drugs under Experimental and Clinical Research

Volumn 26, Issue 5-6, 2000, Pages 141-147

  Roublevskaia, I N ^a   Haake, A R ^a   Ludlow, J W ^a   Polevoda, B V ^a  

^a UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIN DEPENDENT KINASE 1; CYCLIN DEPENDENT KINASE 2; CYCLINE; NSC 631570; PROTEIN BAX; PROTEIN BCL 2; PROTEIN P27; UKRAIN;

APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CELL CYCLE G2 PHASE; CELL GROWTH; CONCENTRATION RESPONSE; CONTROLLED STUDY; HUMAN; HUMAN CELL; PROSTATE CARCINOMA; PROTEIN EXPRESSION;

ALKALOIDS; ANTINEOPLASTIC AGENTS, PHYTOGENIC; APOPTOSIS; BCL-2-ASSOCIATED X PROTEIN; BERBERINE ALKALOIDS; BLOTTING, WESTERN; CELL CYCLE; CELL CYCLE PROTEINS; CYCLIN-DEPENDENT KINASE INHIBITOR P27; CYCLIN-DEPENDENT KINASES; DNA, NEOPLASM; FLOW CYTOMETRY; HUMANS; MALE; PHENANTHRIDINES; PROSTATIC NEOPLASMS; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-BCL-2; TUMOR CELLS, CULTURED; TUMOR SUPPRESSOR PROTEINS;

EID: 0034447833     PISSN: 03786501     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. Prostate cancer: Where we are and where are we going?
2. Chemoprevention of urological cancer
3. Molecular biology of prostate development and prostate cancer
4. Future prospects in prostate cancer
5. Ukrain both as an anticancer and immunoregulatory agent
6. Ukrain (NSC-631570) in experimental and clinical studies: A review
7. Activation of spleen cell lytic activity by the alkaloid thiophosphoric acid derivative: Ukrain
8. Semisynthetic antitumor alkaloid derivatives as antiviral and potential anti-HIV preparations
9. Cytostatic and cytotoxic effects of Ukrain on malignant cells
10. Influence of Ukrain on human xenographs in vitro
11. Induction of bimodal programmed cell death in malignant cells by the derivative Ukrain (NSC-831570)
12. Ukrain (NSC-631570) inhibits angiogenic differentiation of human endothelial cells in vitro
13. Selective inhibition of in vitro cell growth by anti-tumor drug Ukrain
14. Cyclin-dependent kinases. Engines, clocks, and microprocessor
15. 1-phase progression
16. Kip1, a cyclin-dependent kinase inhibitor and a potential mediator of extracellular antimitogenic signals
17. p27kip1: A multifunctional cyclin-dependent kinase inhibitor with prognostic significance in human cancers
18. Promoting apoptosis: A novel activity associated with the cyclin-dependent kinase inhibitor p27
19. Bcl-2 and the regulation of programmed cell death
20. Tumor supressor p53 is a direct transcriptional activator of the human bax gene
21. NS398, a selective cyclooxygenase-2 inhibitor, induces apoptosis and down-regulates bcl-2 expression in LNCaP cells
22. Fas-mediated apoptosis in human prostatic carcinoma cell lines
23. p53 oncogene mutations in three human prostate cancer cell lines
24. Target to apoptosis: A hopeful weapon for prostate cancer
25. bcl-2/bax ration as a predictive marker for therapeutic response to radiotherapy inpatients with prostate cancer
26. Linomide inhibits angiogenesis, growth, metastasis, and macrophage infiltration within rat prostatic cancers
27. Induction of apoptosis by lapachone in human prostate cancer cells
28. 2/M arrest and apoptosis in human epidermoid carcinoma cell lines by semisynthetic drug Ukrian
29. The antimitotic effects of Ukrain, a Chelidonium majus alkaloid derivative, are reversible in vitro